Elevated expression of PKCβ seems to be an early event in colon cancer development [57] and transgenic overexpression of PKCβII in the intestine induces hyper-proliferation and an invasive phenotype in epithelial cells [58,59]. Here, PRKCB is linked to malignant colon neoplasm.